Usual Care
OtherNormal care for hypertensive patients with risk factors for CHD
NCT Number: NCT00709787
To assess the pattern of hypertension in the population in terms of presence of additional risk factors (ARF) and cardiovascular risk stratification.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Pfizer Investigational Site, Varaždin, Croatia
routine physician visits
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Normal care for hypertensive patients with risk factors for CHD
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02579655
Brain Diseases, Cardiovascular Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT04645732
Arthritis, Behavior
Holbæk, Denmark
View Trial DetailsNCT00006294
Cardiovascular Diseases, Coronary Disease
Lexington, Kentucky, United States
View Trial DetailsNCT04492384
Body Weight, CKD
Moscow, Russia
View Trial Details